Page last updated: 2024-09-03

n,n-dimethyldoxorubicin and Cardiac Diseases

n,n-dimethyldoxorubicin has been researched along with Cardiac Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Akkermans, JJ; Arens, R; Bakker, JM; Bellin, M; BorrĂ s, DM; Gerhardt, S; Giacomelli, E; Li, J; Li, X; Mummery, CL; Neefjes, J; Orlova, V; Overkleeft, HS; Pang, B; Qiao, X; Rutten, A; Smit, L; Smits, AM; Song, JY; Tertoolen, LGJ; van der Zanden, SY; van Duikeren, S; van Gils, N; van Herwaarden, T; van Tellingen, O; Wander, DPA; Zuur, CL1

Other Studies

1 other study(ies) available for n,n-dimethyldoxorubicin and Cardiac Diseases

ArticleYear
Uncoupling DNA damage from chromatin damage to detoxify doxorubicin.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 06-30, Volume: 117, Issue:26

    Topics: Animals; Antineoplastic Agents; Cell Line; Chromatin; DNA Damage; Doxorubicin; Heart Diseases; Histones; Humans; Leukemia, Myeloid, Acute; Mice

2020